ATE302004T1 - Stabile orale zusammensetzung enthaltend benzimidazol derivate - Google Patents
Stabile orale zusammensetzung enthaltend benzimidazol derivateInfo
- Publication number
- ATE302004T1 ATE302004T1 AT01978022T AT01978022T ATE302004T1 AT E302004 T1 ATE302004 T1 AT E302004T1 AT 01978022 T AT01978022 T AT 01978022T AT 01978022 T AT01978022 T AT 01978022T AT E302004 T1 ATE302004 T1 AT E302004T1
- Authority
- AT
- Austria
- Prior art keywords
- composition containing
- oral composition
- benzimidazole derivatives
- stable oral
- containing benzimidazole
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- -1 benzimidazole compound Chemical group 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BE2000/000126 WO2002032427A1 (en) | 2000-10-20 | 2000-10-20 | Stable oral formulation containing benzimidazole derivative |
| PCT/BE2001/000184 WO2002032425A2 (en) | 2000-10-20 | 2001-10-18 | Stable oral formulation containing benzimidazole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302004T1 true ATE302004T1 (de) | 2005-09-15 |
Family
ID=3862554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01978022T ATE302004T1 (de) | 2000-10-20 | 2001-10-18 | Stabile orale zusammensetzung enthaltend benzimidazol derivate |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20040043069A1 (de) |
| EP (1) | EP1326609B1 (de) |
| AT (1) | ATE302004T1 (de) |
| AU (3) | AU2001211213A1 (de) |
| CA (1) | CA2426175A1 (de) |
| DE (1) | DE60112781T2 (de) |
| DK (1) | DK1326609T3 (de) |
| WO (2) | WO2002032427A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| WO2004062552A2 (en) * | 2003-01-09 | 2004-07-29 | Galephar M/F | Pharmaceutical composition containing a nsaid and a benzimidazole derivative |
| EP1594479A1 (de) * | 2003-01-31 | 2005-11-16 | Ranbaxy Laboratories Limited | Stabile orale benzimidazol-zusammensetzungen und verfahren zu ihrer herstellung |
| CA2469427A1 (en) * | 2004-06-01 | 2005-12-01 | Pharmascience Inc. | Dry mixed dosage form containing benzimidazole derivatives |
| US7378508B2 (en) | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
| GB0606212D0 (en) * | 2006-03-28 | 2006-05-10 | Karobio Ab | Pharmaceutical compositions |
| US20080176927A1 (en) * | 2007-01-19 | 2008-07-24 | Optimer Pharmaceuticals, Inc. | Compositions of stable tiacumicins |
| RS62327B1 (sr) | 2010-01-28 | 2021-10-29 | Eagle Pharmaceuticals Inc | Formulacije bendamustina |
| CA2792647A1 (en) * | 2010-03-10 | 2011-09-15 | Nogra Pharma Limited | Compositions for colon lavage and methods of making and using same |
| DK2827862T3 (da) | 2012-03-20 | 2024-02-12 | Eagle Pharmaceuticals Inc | Formuleringer af bendamustin |
| HRP20230276T1 (hr) | 2012-03-20 | 2023-04-28 | Eagle Pharmaceuticals, Inc. | Tekući pripravci bendamustina za uporabu u postupku liječenja stanja koja reagiraju na bendamustin kod pacijenata kojima za primjenu trebaju reducirani volumeni |
| JO3464B1 (ar) | 2013-01-15 | 2020-07-05 | Astellas Pharma Europe Ltd | التركيبات الخاصة بمركبات التياكوميسين |
| WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| CN113384547B (zh) * | 2021-06-25 | 2024-03-19 | 上海信谊万象药业股份有限公司 | 一种奥美拉唑铝碳酸镁复合片及其制备工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
| SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
| US20020039597A1 (en) * | 1998-04-20 | 2002-04-04 | Koji Ukai | Stabilized compositions containing benzimidazole-type compounds |
| US6303607B1 (en) * | 1998-09-10 | 2001-10-16 | Cv Therapeutics, Inc. | Method for administering a sustained release ranolanolazine formulation |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| DE19918434A1 (de) * | 1999-04-23 | 2000-10-26 | Basf Ag | Feste Pharmazeutische Formulierungen von säurelabilen Protonenpumpenblockern |
| US6262085B1 (en) * | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
-
2000
- 2000-10-20 WO PCT/BE2000/000126 patent/WO2002032427A1/en not_active Ceased
- 2000-10-20 AU AU2001211213A patent/AU2001211213A1/en not_active Withdrawn
-
2001
- 2001-10-18 CA CA002426175A patent/CA2426175A1/en not_active Abandoned
- 2001-10-18 DK DK01978022T patent/DK1326609T3/da active
- 2001-10-18 DE DE60112781T patent/DE60112781T2/de not_active Expired - Lifetime
- 2001-10-18 WO PCT/BE2001/000184 patent/WO2002032425A2/en not_active Ceased
- 2001-10-18 AU AU2002210284A patent/AU2002210284B2/en not_active Expired
- 2001-10-18 AU AU1028402A patent/AU1028402A/xx active Pending
- 2001-10-18 AT AT01978022T patent/ATE302004T1/de not_active IP Right Cessation
- 2001-10-18 US US10/399,482 patent/US20040043069A1/en not_active Abandoned
- 2001-10-18 EP EP01978022A patent/EP1326609B1/de not_active Expired - Lifetime
-
2007
- 2007-04-23 US US11/790,054 patent/US20070196486A1/en not_active Abandoned
-
2008
- 2008-08-25 US US12/197,900 patent/US20080311204A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002210284B2 (en) | 2006-11-16 |
| US20070196486A1 (en) | 2007-08-23 |
| US20080311204A1 (en) | 2008-12-18 |
| CA2426175A1 (en) | 2002-04-25 |
| EP1326609B1 (de) | 2005-08-17 |
| AU2001211213A1 (en) | 2002-04-29 |
| DE60112781D1 (de) | 2005-09-22 |
| EP1326609A2 (de) | 2003-07-16 |
| US20040043069A1 (en) | 2004-03-04 |
| DK1326609T3 (da) | 2006-01-02 |
| WO2002032427A1 (en) | 2002-04-25 |
| AU1028402A (en) | 2002-04-29 |
| WO2002032425A2 (en) | 2002-04-25 |
| WO2002032425A3 (en) | 2003-01-16 |
| DE60112781T2 (de) | 2006-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60112781D1 (de) | Stabile orale zusammensetzung enthaltend benzimidazol derivate | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| CY1108532T1 (el) | Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων | |
| ATE329584T1 (de) | Orale dosiszusammensetzung mit verlängerter freigabe | |
| DE69907977D1 (de) | Pyrrolobenzodiazepine | |
| ATE392464T1 (de) | Zusammensetzungen enthaltend verzweigte primäre alkohole und deren derivate | |
| DK0381446T3 (da) | Orale anti-svampepræparater | |
| CY1106522T1 (el) | Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο | |
| ECSP034896A (es) | Derivados aromaticos de acidos dicarboxilicos | |
| CY1106076T1 (el) | Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια | |
| DE60138706D1 (de) | Missbrauchssichere orale opioid-agonist zubereitungen | |
| ATE331500T1 (de) | Synergistische orale zusammensetzung gegen zahnbelag und gingivitis | |
| CY1110258T1 (el) | Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης | |
| EE200300048A (et) | Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| CY1107789T1 (el) | Ανθελμινθικαι συνθεσεις περιεχουσαι συνδυασμους αβερμεκτινων ή μιλβεμυκινων μετα δις-αρυλο ενωσεων | |
| TR200301723T4 (tr) | 1,3 Dihidro-2H-indol-2 one türevleri ve bunların, arginin-vasopressin' in V1B veya V1B reseptörleri için bağ maddeleri olarak kullanımı | |
| BR0204678A (pt) | Inibidor de nf-kb contendo derivado de ácido benzóico substituìdo como ingrediente ativo | |
| IL155937A0 (en) | Imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same | |
| DK1274427T3 (da) | Formulering af substituerede benzimidazoler | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| CY1106712T1 (el) | Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης | |
| ATE432075T1 (de) | Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidylene)-5h-be zoä5,6ü-cyclo-heptaä1,2-büpyridin | |
| EP1345582A4 (de) | Orale zusammensetzungen gegen halitose | |
| ATE256124T1 (de) | Substituierte benzimidazole, ihre herstellung und ihre verwendung als mittel gegen parasitäre protozoen | |
| AR028122A1 (es) | Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |